AGMB · CIK 0002020932

AgomAb Therapeutics NV

Annual figures, as reported.

Biological Products, (No Diagnostic Substances)
Company profile
Nasdaq · AGMBHQ AntwerpenIncorporated in C9Fiscal year ends Dec 31Non-accelerated filer Emerging growth company
No structured annual financials are available for this filer — funds, trusts and shell companies often file without them.

Latest filings

the most recent regulatory filings
6-KForeign issuer report2026-06-23 ↗6-KForeign issuer report2026-05-27 ↗SCHEDULE 13GSEC filing2026-05-15 ↗SCHEDULE 13GSEC filing2026-05-15 ↗SCHEDULE 13GSEC filing2026-05-06 ↗6-KForeign issuer report2026-04-24 ↗20-FAnnual report (foreign issuer)2026-04-23 ↗SCHEDULE 13GSEC filing2026-04-16 ↗3OWNERSHIP DOCUMENT2026-03-18 ↗3OWNERSHIP DOCUMENT2026-03-18 ↗

Company logos by Elbstream and unavatar.

All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.